790 related articles for article (PubMed ID: 17151667)
1. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL
Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells.
Piccirillo SG; Vescovi AL
Ernst Schering Found Symp Proc; 2006; (5):59-81. PubMed ID: 17939295
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma and stem cells.
Altaner C
Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
[TBL] [Abstract][Full Text] [Related]
4. Cancer: stem cells and brain tumours.
Dirks PB
Nature; 2006 Dec; 444(7120):687-8. PubMed ID: 17151644
[No Abstract] [Full Text] [Related]
5. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
6. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
7. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity.
Zhuang W; Li B; Long L; Chen L; Huang Q; Liang Z
Int J Cancer; 2011 Dec; 129(11):2720-31. PubMed ID: 21384342
[TBL] [Abstract][Full Text] [Related]
8. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S
Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433
[TBL] [Abstract][Full Text] [Related]
10. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous phenotype of human glioblastoma: in vitro study.
Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
[TBL] [Abstract][Full Text] [Related]
12. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.
Chirasani SR; Sternjak A; Wend P; Momma S; Campos B; Herrmann IM; Graf D; Mitsiadis T; Herold-Mende C; Besser D; Synowitz M; Kettenmann H; Glass R
Brain; 2010 Jul; 133(Pt 7):1961-72. PubMed ID: 20513660
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.
Venugopal C; Li N; Wang X; Manoranjan B; Hawkins C; Gunnarsson T; Hollenberg R; Klurfan P; Murty N; Kwiecien J; Farrokhyar F; Provias JP; Wynder C; Singh SK
Stem Cell Res; 2012 Mar; 8(2):141-53. PubMed ID: 22265735
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.
Lombardo Y; Scopelliti A; Cammareri P; Todaro M; Iovino F; Ricci-Vitiani L; Gulotta G; Dieli F; de Maria R; Stassi G
Gastroenterology; 2011 Jan; 140(1):297-309. PubMed ID: 20951698
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma cancer stem cells--from concept to clinical application.
Stopschinski BE; Beier CP; Beier D
Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
[TBL] [Abstract][Full Text] [Related]
18. Characterization of glioma stem-like cells from human glioblastomas.
Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y
Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568
[TBL] [Abstract][Full Text] [Related]
19. Targeting brain-tumor stem cells.
Stupp R; Hegi ME
Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
[No Abstract] [Full Text] [Related]
20. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.
Jamal M; Rath BH; Tsang PS; Camphausen K; Tofilon PJ
Neoplasia; 2012 Feb; 14(2):150-8. PubMed ID: 22431923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
